low estrogen [fndg]
Dose [qnco]
drospirenone [orch, phsu]
Combination [qlco]
effects [qlco]
Metabolism [orgf]
cardiovascular risk factor [dsyn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
Evaluate [ftcn]
effects [qlco]
Daily [tmco]
mg% [qnco]
Plus [qlco]
drospirenone [orch, phsu]
Oral [spco]
Formulation [resa]
mg% [qnco]
Metabolism [orgf]
Lipid [lipd]
Profile [lbpr]
Endothelial [tisu]
function [phsf]
Symptomatic [ftcn]
Health [idcn]
Menopausal [phsf]
Women [popg]
Design [acty]
randomized [resa]
Double-Blind Study [resa]
setting [ftcn]
Operative [tmco]
Division [topp]
Endocrinology [bmod]
Gynaecology [bmod]
Catholic [popg]
University [mnob, orgt]
Heart [bpoc]
Rome [geoa]
Italy [geoa]
postmenopausal [tmco]
Women [popg]
intervention [hlca]
Patients [podg]
Submitted [ftcn]
Receive [qlco]
treatment [ftcn]
Oral [spco]
Dose [qnco]
mg% [qnco]
Plus [qlco]
drospirenone [orch, phsu]
mg% [qnco]
Group A [clas]
placebo [topp]
Group [idcn]
Main [qlco]
outcome measure [qnco]
Hormonal [qlco]
Lipid [lipd]
Assessment [hlca]
Evaluation [ftcn]
Glucose [bacs, carb, phsu]
insulin metabolism [moft]
Clamp [medd]
Test [lbpr]
Oral Glucose Tolerance Test [diap]
Evaluation [ftcn]
Endothelial [tisu]
function [phsf]
vascular reactivity [clna]
Test [lbpr]
Total Cholesterol [lbpr]
Low density lipoprotein cholesterol level [lbpr]
Nonesterified Fatty Acids [lipd]
Levels [qlco]
Decreased [qnco]
months [tmco]
High density lipoprotein [aapp, bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein A-I [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
treatment [ftcn]
Metabolism [orgf]
Observed [ftcn]
reduction [npop]
Area [geoa]
Curve [spco]
Insulin [aapp, horm, phsu]
months [tmco]
therapy [ftcn]
Endothelial [tisu]
function [phsf]
treatment [ftcn]
Improvement [cnce]
Flow [npop]
mediated [socb]
Dilatation [topp]
Nitrate [chvs]
mediated [socb]
Dilatation [topp]
Values [qlco]
months [tmco]
Observed [ftcn]
Low dose [qnco]
drospirenone [orch, phsu]
treatment [ftcn]
Negative [qlco]
Carbohydrate Metabolism [moft]
ACT [topp]
Neutral [qlco]
Insulin Sensitivity [patf]
treatment [ftcn]
Induced [ftcn]
Favorable [qlco]
Lipid [lipd]
Profile [lbpr]
Improvement [cnce]
vascular reactivity [clna]
R- [spco]
American [popg]
society [orgt]
Reproductive Medicine [bmod]
